Mirco Govoni
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pharmacokinetics and absorption, distribution, metabolism and excretion profiling of tanimilast following an intravenous 14C-microtracer coadministered with an inhaled dose in healthy male individuals.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: July 31, 2024
Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease.
Journal: American journal of respiratory and critical care medicine
Published: May 16, 2023
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
Journal: Journal of translational medicine
Published: March 26, 2022
Therapeutic Drug Monitoring Strategies for Envarsus in De Novo Kidney Transplant Patients Using Population Modelling and Simulations.
Journal: Advances in therapy
Published: July 24, 2021
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.
Journal: Frontiers in pharmacology
Published: July 13, 2021
A Novel Processing-Free Method for RNAseq Analysis of Spontaneous Sputum in Chronic Obstructive Pulmonary Disease.
Journal: Frontiers in pharmacology
Published: May 04, 2021
COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum.
Journal: Journal of cellular and molecular medicine
Published: September 26, 2020
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.
Journal: Respiratory research
Published: April 11, 2020
COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.
Journal: The European respiratory journal
Published: February 04, 2020
Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
Journal: Respiratory research
Published: October 17, 2019
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
Journal: Respiratory research
Published: June 12, 2019
Last Updated: 09/26/2026